Font Size: a A A

Biopharmaceutical Class In Our Country Listed Company Profitability Analysis

Posted on:2013-03-06Degree:MasterType:Thesis
Country:ChinaCandidate:Q LiuFull Text:PDF
GTID:2249330377956296Subject:Statistics
Abstract/Summary:PDF Full Text Request
In the second half of2010, the biopharmaceutical industry is one of thecountries included in the focus on the development and nurturing of the sevenemerging strategic industries. Biopharmaceutical listed company as a livingorganism, profitability is the basis for its survival, it is the viability force ofdevelopment, innovation, resilience, cohesion and bearing capacity andoverall performance, but also the strength of competitive the primary logo.The profitability of listed companies in biopharmaceutical investors,investment decisions, the most basic and important judgment in accordancewith the basis, but also the creditors an accurate assessment of the solvency oflisted companies to control credit risk. So whether it is the investors, creditors,or a listed company management personnel, an accurate analysis tounderstand its profitability is a must.This article is the view of the above actual needs from four modules tobegin the analysis of the profitability of listed companies, production andoperation of profitability, asset profitability, profitability and cost control ofthe owner of investment profitability. In this paper, primary considerationprofitability indicators totaling29by the correlation coefficient in theapplication of statistical methods and analysis of variance, according to theprinciple of similar substitution and differentiation index screening, andultimately select13indicators were summarized to the above four module. In the selection of the indicators, the reliance on statistical methods and theactual data, rather than subjective selection based on financial theory. Costcontrol in the four modules profitability, but also from the perspective of theopposite direction to cut expenditure to the critical analysis of profitability,made an attempt.From country Tyan database provides nearly140biopharmaceuticallisted company financial data, random sample of64companies, and detaileddata on13indicators from2001to2010. From production operations, assets,owner of the investment, cost control, these four aspects is described in theprofitability of listed companies on biopharmaceutical. Subsequently, selectedwith the pillar industries of real estate and automobile manufacturing, theapplication of analysis of variance, a comparative analysis of the profitabilityof listed companies in three industry.Finally, selection of structural equation modeling, the modeling analysis.Borrow the idea of the structural equation model with significant variablescan be measured-the selected13indicators to reflect the hidden variables arenot directly measure-profitability, very good and fits the theme of this paperis to study and conduct the instance of the application to verify, alsocompleted a statistical method better try on financial applications.
Keywords/Search Tags:Profitability, Production and management, Assets, Owner of the investment, Cost control, Analysis of variance, Structural equation
PDF Full Text Request
Related items